Alpha 2.0
Login Register
» Authors » Giuliano Barsotti

Giuliano Barsotti

Explore the profile of Giuliano Barsotti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 448
Followers 0
Related Specialties
Nephrology
General Surgery
Nutritional Sciences
Top 10 Co-Authors
Adamasco Cupisti
Vincenzo Panichi
Sabrina Paoletti
Mario Meola
Claudia DAlessandro
Ester Morelli
Erica Panicucci
Giovanni Manca Rizza
Cristina Consani
Emanuela Mantuano
Published In
Nephrol Dial Transplant
J Nephrol
J Ren Nutr
Biomed Pharmacother
Ren Fail
Affiliations
Soon will be listed here.
Recent Articles
1.
Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: a historical cohort controlled study
Bellizzi V, Chiodini P, Cupisti A, Viola B, Pezzotta M, De Nicola L, et al.
Nephrol Dial Transplant . 2014 Aug; 30(1):71-7. PMID: 25082793
Background: Very low-protein intake during chronic kidney disease (CKD) improves metabolic disorders and may delay dialysis start without compromising nutritional status, but concerns have been raised on a possible negative...
2.
Creatinine clearance, cystatin C, beta2-microglobulin and TATI as markers of renal function in patients with proteinuria
Tramonti G, Cipollini I, Annichiarico C, Lorusso P, Panicucci E, Mariani G, et al.
J Nephrol . 2012 Feb; 25(6):976-82. PMID: 22307441
Background: Proteinuria is a risk factor for end-stage renal disease (ESRD). Creatinine clearance (CrCl) is usually used as a marker to monitor the progression of ESRD, while cystatin C (CYST)...
3.
Use of ultrasound to assess the response to therapy for secondary hyperparathyroidism
Meola M, Petrucci I, Colombini E, Barsotti G
Am J Kidney Dis . 2011 Jul; 58(3):485-91. PMID: 21715073
Secondary hyperparathyroidism (SHPT) is a common complication in patients with chronic kidney disease. In SHPT, the biology of parathyroid cells changes significantly toward diffuse nodular hyperplasia. Currently, diagnosis of SHPT...
4.
Lipoprotein glomerulopathy: first report of 2 not consanguineous Italian men from the same town
Pasquariello A, Pasquariello G, Innocenti M, Minnei F, Funel N, Lorusso P, et al.
J Nephrol . 2011 May; 24(3):381-5. PMID: 21534236
It is well known that the abnormal accumulation of lipids can occur in kidneys of patients affected by some metabolic disorders due either to inherited enzymatic deficiency or to an...
5.
Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study
Panichi V, Rosati A, Bigazzi R, Paoletti S, Mantuano E, Beati S, et al.
Nephrol Dial Transplant . 2011 Feb; 26(8):2641-8. PMID: 21325348
Background: Resistance to erythropoiesis-stimulating agents (ESAs) is often associated with chronic inflammation. Here, we investigated how anaemia, ESA resistance and the plasma levels of biological markers of inflammation could influence...
6.
A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial
Panichi V, Rosati A, Paoletti S, Ferrandello P, Migliori M, Beati S, et al.
Blood Purif . 2011 Jan; 32(1):7-14. PMID: 21242686
Background: Oxidative stress is prevalent in dialysis patients and has been implicated in the pathogenesis of cardiovascular disease and anemia. Vitamin E is a fat-soluble antioxidant that plays a central...
7.
A case of pheochromocytoma presenting as secondary hyperaldosteronism, hyperparathyroidism, diabetes and proteinuric renal disease
Bernini M, Bacca A, Casto G, Carli V, Cupisti A, Carrara D, et al.
Nephrol Dial Transplant . 2011 Jan; 26(3):1104-7. PMID: 21212167
A 35-year-old woman was admitted to the Nephrology and Dialysis Unit of Pisa University for hypertension, hypokalaemia, renal impairment, proteinuria and hyperglycaemia. plasma renin activity (PRA) and plasma aldosterone were...
8.
Impact of calcium, phosphate, PTH abnormalities and management on mortality in hemodialysis: results from the RISCAVID study
Panichi V, Bigazzi R, Paoletti S, Mantuano E, Beati S, Marchetti V, et al.
J Nephrol . 2010 Mar; 23(5):556-62. PMID: 20349412
Background: Despite substantial progress in medical care, the mortality rate remains unacceptably high in dialysis patients. Evidence suggests that bone mineral dismetabolism (CKD-MBD) might contribute to this burden of death....
9.
Dimethylarginine levels and nutritional status in hemodialysis patients
Cupisti A, Saba A, DAlessandro C, Meola M, Panicucci E, Panichi V, et al.
J Nephrol . 2009 Oct; 22(5):623-9. PMID: 19809995
Background: Asymmetric dimethylarginine (ADMA)and symmetric dimethylarginine (SDMA) originate from hydrolysis of methylated proteins, including dietary proteins, and are retained in end-stage renal disease(ESRD). This study aimed to detect the correlation...
10.
Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism
Meola M, Petrucci I, Barsotti G
Nephrol Dial Transplant . 2009 Feb; 24(3):982-9. PMID: 19181759
Background: The effect of cinacalcet on the structural pattern of hyperplastic parathyroid glands was evaluated, using high-resolution colour Doppler (CD) sonography, in haemodialysis patients with severe, inadequately controlled, secondary hyperparathyroidism...